Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/21/2000 | WO2000076541A1 Pneumococcal surface protein combination vaccine |
12/21/2000 | WO2000076540A2 Streptococcus pneumoniae proteins and vaccines |
12/21/2000 | WO2000076532A1 νO-CONOPEPTIDES AND THEIR USE AS LOCAL ANESTHETICS |
12/21/2000 | WO2000076531A1 47 human secreted proteins |
12/21/2000 | WO2000076530A1 49 human secreted proteins |
12/21/2000 | WO2000076450A2 Recombinant adenoviruses for the sodium/iodide symporter (nis) |
12/21/2000 | WO2000076310A1 Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions |
12/21/2000 | WO2000076309A2 Non-human transgenic animals deficient in gas6 function and their use |
12/21/2000 | WO2000076308A1 Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism |
12/21/2000 | WO2000066736B1 Growth factor homolog zvegf4 |
12/21/2000 | WO2000055363A3 Analysis of differential gene expression |
12/21/2000 | WO2000055312A3 Rt-pcr of clonal neurospheres |
12/21/2000 | WO2000054574A3 Chemical and physical treatment that stimulate recombination |
12/21/2000 | WO2000053782A3 Herbicide target genes and methods |
12/21/2000 | WO2000053780A3 Multiple component rna vector system for expression of foreign sequences |
12/21/2000 | WO2000053761A3 Human cytokine as ligand of the zalpha receptor and uses thereof |
12/21/2000 | WO2000053752A3 Promotion or inhibition of angiogenesis and cardiovascularization |
12/21/2000 | WO2000053737A3 Mitomycin biosynthetic gene cluster |
12/21/2000 | WO2000053732A3 Class ii dna methyltransferases of zea mays |
12/21/2000 | WO2000053628A3 Genes encoding human potassium channel proteins |
12/21/2000 | WO2000052187A3 Enhanced system for construction of adenovirus vectors |
12/21/2000 | WO2000052179A3 Dna binding compound-mediated molecular switch system |
12/21/2000 | WO2000052167A8 Angiopoietin-related protein and nucleic acids |
12/21/2000 | WO2000052056A3 Anti-plasmodium compositions and methods of use |
12/21/2000 | WO2000050596A3 14273 receptor, a novel g-protein coupled receptor |
12/21/2000 | WO2000050062A3 Methods and compositions for altering mucus secretion |
12/21/2000 | WO2000050008A3 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
12/21/2000 | WO2000049158A3 Psa and klk-2 splicing variants |
12/21/2000 | WO2000048631A3 Adjuvant and cell maturation agent |
12/21/2000 | WO2000046394A3 Tryptophan synthase as a site of herbicide action |
12/21/2000 | WO2000046372A3 Pancreatic islet genes regulated by glucose |
12/21/2000 | WO2000046240A3 Polypeptides involved in immune response |
12/21/2000 | WO2000045167A3 Non-invasive method for detecting target rna |
12/21/2000 | WO2000044391A3 Plasminogen kringle 4 region fragments and methods of use |
12/21/2000 | WO2000043510A3 Ras activator nucleic acid molecules - guanine nucleotide releasing factor grf4, polypeptides and methods of use |
12/21/2000 | WO2000042068A3 Hiv related peptides |
12/21/2000 | WO2000037629A3 Method of producing antihypercholesterolemic agents |
12/21/2000 | WO2000035950A3 Reagents and methods useful for detecting diseases of the breast |
12/21/2000 | WO2000027860A8 Polynucleotide crosslinking agents |
12/21/2000 | EP1144672A3 Tryptophan synthase as a site of herbicide action |
12/21/2000 | EP1144612A3 Method of producing antihypercholesterolemic agents |
12/21/2000 | DE19928313A1 Verfahren zur Veränderung von Peptidsynthefasen in der Weise, daß sie ihre Substrataminosäuren N-methylieren können Method for changing Peptidsynthefasen in such a way that they can make their substrate amino acids N-methylated |
12/21/2000 | DE19928073A1 Transconjugation plasmid for mutating Pasteurellaceae, useful for producing live vaccine strains of the pig pathogen Actinobacillus pleuropneumoniae |
12/21/2000 | DE19928021A1 New nucleic acid encoding testis-specific calpain-11, useful for identifying specific inhibitors for treatment of fertility disorders |
12/21/2000 | DE19927740A1 Preparing an agent for diagnosis or control of microbial infection, useful particularly against Helicobacter, based on identification of essential genes in defective mutants |
12/21/2000 | DE19927575A1 Increasing resistance of crop plants to fungal or bacterial pathogens, by engineering a reduction in activity of flavanone-3-hydroxylase |
12/21/2000 | DE19927574A1 Increasing content of flavonoids and phenols in plants, useful for e.g. preventing cardiovascular disease, by reducing activity of flavanone-3-hydroxylase |
12/21/2000 | DE19927568A1 Increasing resistance of crop plants to chemical stress, especially herbicides, by engineering a reduction in activity of flavanone-3-hydroxylase |
12/21/2000 | CA2751621A1 Hybridomas that undergo class-switching in vitro |
12/21/2000 | CA2391364A1 47 human secreted proteins |
12/21/2000 | CA2391361A1 47 human secreted proteins |
12/21/2000 | CA2390946A1 49 human secreted proteins |
12/21/2000 | CA2387696A1 48 human secreted proteins |
12/21/2000 | CA2387371A1 Helical cytokine zalpha33 |
12/21/2000 | CA2383048A1 49 human secreted proteins |
12/21/2000 | CA2383041A1 49 human secreted proteins |
12/21/2000 | CA2382769A1 42 human secreted proteins |
12/21/2000 | CA2382748A1 50 human secreted proteins |
12/21/2000 | CA2382743A1 48 human secreted proteins |
12/21/2000 | CA2382735A1 49 human secreted proteins |
12/21/2000 | CA2382185A1 48 human secreted proteins |
12/21/2000 | CA2379327A1 Pneumococcal surface protein combination vaccine |
12/21/2000 | CA2378745A1 Ligand-conjugated oligomeric compounds |
12/21/2000 | CA2378512A1 Characterization of the yeast transcriptome |
12/21/2000 | CA2377592A1 Method of modifying peptide synthetases such that they can n-methylate their substrate amino acids |
12/21/2000 | CA2376970A1 Thermogenesis-associated genes and thermogenesis-associated proteins of plant |
12/21/2000 | CA2376956A1 Charged compounds facilitate viral transduction of cells |
12/21/2000 | CA2376878A1 Promoter enabling transgene expression in the whole plant except in the seed |
12/21/2000 | CA2376735A1 Recombinant adenoviruses for the sodium/iodide symporter (nis) |
12/21/2000 | CA2376717A1 Human poly(adp-ribose) polymerase 2 materials and methods |
12/21/2000 | CA2376675A1 Antagonists of bmp and tgf.beta. signalling pathways |
12/21/2000 | CA2376667A1 Gene expression modulated in gastrointestinal inflammation |
12/21/2000 | CA2376630A1 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt |
12/21/2000 | CA2376621A1 Enzyme selection |
12/21/2000 | CA2376609A1 Method for determining hiv-1 subtype |
12/21/2000 | CA2376559A1 Dna manipulation methods, applications for synthetic enzymes and use for polyketide production |
12/21/2000 | CA2376532A1 Biosensors which utilize charge neutral conjugated polymers |
12/21/2000 | CA2376523A1 Dna pcv-vaccine |
12/21/2000 | CA2376487A1 Methods for enhancing the production of cytokines in cell culture |
12/21/2000 | CA2376467A1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production |
12/21/2000 | CA2376446A1 Nucleic acid fragment and vector containing halogenase and method for the halogenation of chemical compounds |
12/21/2000 | CA2376437A1 Promoter system and production and use of the same |
12/21/2000 | CA2376432A1 Novel protein and dna thereof |
12/21/2000 | CA2376429A1 Process for making fluorinated polymer adsorbent particles |
12/21/2000 | CA2376421A1 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
12/21/2000 | CA2376392A1 Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells |
12/21/2000 | CA2376389A1 Cloning and expression of a novel 5-ht4 receptor |
12/21/2000 | CA2376357A1 .mu.o-conopeptides and their use as local anesthetics |
12/21/2000 | CA2376288A1 Use of antibodies against cd20 for the treatment of the graft versus host disease |
12/21/2000 | CA2376243A1 Gustatory receptors in drosophila |
12/21/2000 | CA2376232A1 A structured peptide scaffold for displaying turn libraries on phage |
12/21/2000 | CA2375998A1 Gene and protein sequences of phage t4 gene 35 |
12/21/2000 | CA2375825A1 Complement-resistant non-mammalian dna viruses and uses thereof |
12/21/2000 | CA2375619A1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf) |
12/21/2000 | CA2375423A1 Promoters from atlantic salmon |
12/21/2000 | CA2375390A1 Genomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms |
12/21/2000 | CA2375386A1 Lipocalin family protein |
12/21/2000 | CA2375346A1 Fibrin sealant as a transfection/transformation vehicle for gene therapy |
12/21/2000 | CA2375320A1 Dna vaccines for pets or for animals used in sports |
12/21/2000 | CA2375317A1 Method of increasing the content of fatty acids in plant seeds |